Microbot Medical Inc. (MBOT) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Microbot Medical Inc. (MBOT) closed at USD 0.99 on 2026-10-14, a change of -54.8 % over the past year, with a market capitalization of USD 63.81M.

Microbot Medical Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Microbot Medical Inc. key figures

Previous close

USD 0.99 (2026-10-14)

1-year change

-54.8 %

Market cap

USD 63.81M

Enterprise value

USD -2.68M

P/E ratio (trailing)

-4.13

P/E ratio (forward)

-3.13

EPS (trailing)

-0.23

EPS (forward)

-0.30

PEG ratio

0.70

Price to book

0.93

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

14.00

Employees

43

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Microbot Medical Inc.

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Microbot Medical Inc. and compare it with other stocks.